Product Information
VALSARTAN 80 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.0820 per EA under NDC 33342006310. Its NADAC has been published 482 times since Jul 12, 2017.
FDA first approved this application on Sep 16, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
80 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342006310
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA202696FDA Approved
9/16/2016
TE Code
AB
On Market Since
9/19/2016
Pharmacological Classes
Price Statistics
The NADAC for VALSARTAN 80 MG TABLET has been published 482 times since Jul 12, 2017, and over the history we have for it it has declined 28.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0820 per EA |
|---|---|
| All-time high | $0.2875 (Mar 11, 2020) |
| All-time low | $0.0679 (Jun 20, 2018) |
| 52-week high | $0.1270 |
| 52-week low | $0.0820 |
| Median price | $0.1655 |
| Average price | $0.1765 |
| Largest weekly change | +113.5% (Oct 17, 2018) |
| Weeks tracked | 482 |
| Tracking since | Jul 12, 2017 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Valsartan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VALSARTAN 80 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VALSARTAN 80 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.0820 per EA (NDC 33342006310), effective Sep 30, 2026.
How has the price of VALSARTAN 80 MG TABLET changed over time?
Over the history we have for it, the NADAC for VALSARTAN 80 MG TABLET has declined 28.0%. It has been tracked across 482 weekly CMS publications since Jul 12, 2017.
What are the highest and lowest recorded NADAC prices for VALSARTAN 80 MG TABLET?
Since Jul 12, 2017, the NADAC for VALSARTAN 80 MG TABLET has ranged from a low of $0.0679 (Jun 20, 2018) to a high of $0.2875 (Mar 11, 2020), with a median of $0.1655 per EA.
Are there cheaper alternatives to VALSARTAN 80 MG TABLET?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VALSARTAN 80 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures VALSARTAN 80 MG TABLET?
VALSARTAN 80 MG TABLET (NDC 33342006310) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.